Canabo Medical Landmark Observational Study Demonstrates Cannabis as Effective Substitute for Benzodiazepine


canabo-medicalMilestone Study Shows Dramatic Reduction In Pharmaceutical Reliance Among Canadian Medical Cannabis Patients

Canabo Medical Inc. observational study finds nearly fifty per cent drop in benzodiazepine use within months of cannabis treatment

TORONTO, ON – (April 7, 2017) – Today, Canabo Medical Inc. (TSXV: CMM) (OTC: CAMDF)

... read more at: https://www.newcannabisventures.com/canabo-medical-landmark-observational-study-demonstrates-cannabis-as-effective-substitute-for-benzodiazepine/